Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
MP Materials
MP
$7.8B
| $2.06M | ﹤0.01% |
72,962
+52,604
| +258% | +$1.59M |
|
2127
iShares US Aerospace & Defense ETF
ITA
$14.4B
| $2.05M | ﹤0.01% |
17,848
+12,676
| +245% | +$1.44M |
|
2128
Sphere Entertainment
SPHR
$5.29B
| $2.05M | ﹤0.01% |
34,716
+27,641
| +391% | +$1.49M |
|
|
ALLK
2129
DELISTED
Allakos
ALLK
| $2.05M | ﹤0.01% |
460,328
+56,502
| +14% | +$361K |
|
2130
Coca-Cola Consolidated
COKE
$12B
| $2.05M | ﹤0.01% |
38,270
+9,210
| +32% | +$476K |
|
2131
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
| $2.05M | ﹤0.01% |
18,745
| – | – |
|
2132
WSFS Financial
WSFS
$4.19B
| $2.05M | ﹤0.01% |
54,413
+24,708
| +83% | +$1.13M |
|
|
BCPC
2133
Balchem Corp
BCPC
$5.58B
| $2.05M | ﹤0.01% |
16,170
+700
| +5% | +$90.5K |
|
2134
CALL
BP
BP
$114B
| $2.04M | ﹤0.01% |
+53,900
| New | +$2.01M |
|
|
VRE
2135
DELISTED
Veris Residential
VRE
| $2.04M | ﹤0.01% |
139,391
-158,852
| -53% | -$2.53M |
|
2136
CALL
Lufax Holding
LU
$1.31B
| $2.04M | ﹤0.01% |
250,000
-171,250
| -41% | -$1.64M |
|
2137
Regal Rexnord
RRX
$14.1B
| $2.04M | ﹤0.01% |
14,494
-6,624
| -31% | -$959K |
|
|
HPP
2138
Hudson Pacific Properties
HPP
$786M
| $2.04M | ﹤0.01% |
43,788
-34,860
| -44% | -$2.24M |
|
2139
Vontier
VNT
$4.62B
| $2.04M | ﹤0.01% |
74,485
+50,334
| +208% | +$1.22M |
|
|
B
2140
DELISTED
Barnes Group Inc.
B
| $2.03M | ﹤0.01% |
50,507
+26,480
| +110% | +$1.11M |
|
2141
Xencor
XNCR
$1.44B
| $2.03M | ﹤0.01% |
72,798
-18,059
| -20% | -$557K |
|
|
CNR
2142
Core Natural Resources Inc
CNR
$4.05B
| $2.03M | ﹤0.01% |
34,821
+6,187
| +22% | +$353K |
|
2143
Alamo Group
ALG
$1.99B
| $2.03M | ﹤0.01% |
11,016
+1,173
| +12% | +$193K |
|
|
WEL
2144
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $2.03M | ﹤0.01% |
192,909
| – | – |
|
2145
iShares MSCI South Africa ETF
EZA
$547M
| $2.02M | ﹤0.01% |
47,949
+47,904
| +106,453% | +$2.07M |
|
2146
Highwoods Properties
HIW
$3.67B
| $2.02M | ﹤0.01% |
87,263
-52,390
| -38% | -$1.41M |
|
2147
PUT
Invesco Solar ETF
TAN
$1.45B
| $2.02M | ﹤0.01% |
26,000
-406,300
| -94% | -$31.1M |
|
|
MBSC
2148
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
| $2.02M | ﹤0.01% |
195,218
| – | – |
|
2149
Oxford Industries
OXM
$568M
| $2.01M | ﹤0.01% |
19,042
-4,266
| -18% | -$477K |
|
|
AGR
2150
DELISTED
Avangrid, Inc.
AGR
| $2.01M | ﹤0.01% |
50,397
+40,691
| +419% | +$1.66M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.